
Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Read More

Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Read More
Antibodies are an invaluable tool in the life sciences, however, despite their importance, many antibodies are experiencing the reproducibility crisis; researchers are using REmAb™ to overcome this. Read More
Veristat regulatory experts weigh in on how to use FDA expedited programs to improve your chances for success and possibly shorten timelines to approval. Read More
Holding frequent meetings with the FDA - such as Type A, Type B and Type C meetings – can help reduce both developments costs and time to approval. Read More
Discussion regarding how OrthoTrophix and Sherpa worked through the clinical supply challenges presented by a frozen drug. Read More
Oncology White Paper: A Sermo/Publicis Health Partnership Read More
If you’re just beginning your EU FMD compliance journey, this guide is for you. The EU Falsified Medicines Directive is full of detail and complexity—and you’ll need to know the ins and outs of the regulation long before... Read More
Organizing the knowledge space around disease is a crucial requirement in the Read More